Description
KB-0742 is a selective CDK9 inhibitor with potent anti-tumor activity in castration-resistant prostate cancer models.
| Product Unit Size | Cost | Quantity | Stock |
|---|
KB-0742 is a selective CDK9 inhibitor with potent anti-tumor activity in castration-resistant prostate cancer models.
| Cas No. | 2170137-61-6 (free base) |
|---|---|
| Purity | ≥98% |
| Formula | C16H25N5 |
| Formula Wt. | 287.41 |
| IUPAC Name | (1S,3S)-3-N-(5-pentan-3-ylpyrazolo[1,5-a]pyrimidin-7-yl)cyclopentane-1,3-diamine |
| Synonym | KB0742, NSC-834161, NSC834161 |
| Appearance | Yellow to brown crystal |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Richters A, Doyle S, Freeman D, et al. Modulating androgen receptor-driven transcription in prostate cancer with selective CDK9 inhibitors. Cell Chem Biol. 2021 Feb 18;28(2):134-147. PMID: 33086052
JAK2 inhibitor
HDAC inhibitor. May reduce blood pressure in hy...
Neuropeptide found in Schistocera gregaria.
Triterpene; potential tyrosinase inhibitor.
Captothecin derivative; topoisomerase I inhibit...
Lincosamide; ribosomal translocation and protei...
HDAC inhibitor, RNA splicing modulator.
Impurity of everolimus
Folic acid analog, derivative of pterin; dihydr...
A peroxisome proliferator-activated receptor ag...
Bisphosphonate; inhibits transfer of farnesyl p...
For use in amino acid analysis.
p110α PI3K inhibitor.
Zika Virus antigen
Endogenous bombesin-like peptide, involved in f...
Prolyl hydroxylase inhibitor.
Isoflavonoid found in Glycyrrhiza; GABA-A posit...
SERM.
p110α PI3K inhibitor.